COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
Harvard University · Massachusetts General Hospital · +1 more institution
Abstract
Patients with coronavirus disease 2019 (COVID-19) have elevated D-dimer levels. Early reports describe high venous thromboembolism (VTE) and disseminated intravascular coagulation (DIC) rates, but data are limited. This multicenter retrospective study describes the rate and severity of hemostatic and thrombotic complications of 400 hospital-admitted COVID-19 patients (144 critically ill) primarily receiving standard-dose prophylactic anticoagulation. Coagulation and inflammatory parameters were compared between patients with and without coagulation-associated complications. Multivariable logistic models examined the utility of these markers in predicting coagulation-associated complications, critical illness,…
Citation impact
- FWCI
- 31.69
- Percentile
- 100%
- References
- 22
Authors
13- HAHanny Al‐SamkariCorresponding
Harvard University, Massachusetts General Hospital
- RSRebecca S. Karp Leaf
Harvard University, Massachusetts General Hospital
- SDSunny Dzik
Harvard University, Massachusetts General Hospital
- JCJonathan Carlson
Harvard University, Massachusetts General Hospital
- AEAnnemarie E. Fogerty
Harvard University, Massachusetts General Hospital
Topics & keywords
- Coronavirus disease 2019 (COVID-19)
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Medicine
- 2019-20 coronavirus outbreak
- Coagulation
- Betacoronavirus
- Virology
- Pandemic
- Good health and well-being